Eggplant

For diagnostic purposes, the dosage of Eggplant extract is highly specialized and must be performed by a trained allergist.

• Skin Prick Test (SPT): One drop of the 1:10 or 1:20 w/v extract is applied to the volar surface of the forearm. A sterile lancet is used to prick the skin through the drop. A positive control (histamine) and a negative control (saline) must be used simultaneously for comparison.
• Intradermal Testing: If the SPT is negative but a high clinical suspicion of allergy remains, a 1:100 to 1:1000 dilution of the extract may be injected intradermally (0.02 mL) to observe for a delayed or more sensitive reaction.
• Oral Challenge: In a clinical setting, a graded oral challenge may involve starting with 1 gram of cooked or raw eggplant, doubling the dose every 15-30 minutes under strict medical supervision until a cumulative dose of 100 grams is reached or a reaction occurs.

Eggplant allergenic extracts are used in children, but with extreme caution.

• Children (Age 2 and older): The procedure for skin prick testing is identical to adults, though the number of simultaneous tests may be limited to reduce patient distress.
• Infants: Testing is generally avoided unless severe systemic reactions have occurred, as skin reactivity in infants can be inconsistent.

Renal Impairment

No specific dosage adjustments are required for diagnostic skin testing in patients with renal impairment, as systemic absorption is minimal. However, for oral concentrated extracts, patients with a GFR < 30 mL/min should use caution due to the potential accumulation of phenolic metabolites.

Hepatic Impairment

No adjustments are typically necessary for diagnostic use. In cases of severe hepatic cirrhosis, the skin's inflammatory response may be blunted, leading to potential false-negative results in allergy testing.

Elderly Patients

Elderly patients (over 65) often exhibit decreased skin turgor and reduced mast cell density. Clinicians may need to apply slightly more pressure during the prick test or rely more heavily on serum IgE (blood) testing to confirm results.

• Preparation: Ensure the skin site is clean and free of topical steroids or antihistamines for at least 7 days prior to testing.
• Administration: The extract should be stored at 2°C to 8°C (36°F to 46°F). Do not freeze. Before use, the vial should be gently swirled to ensure the extract is homogenous.
• Observation: Patients must remain in the medical facility for at least 30 minutes following administration to monitor for systemic allergic reactions.

As Eggplant extract is typically used for one-time diagnostic procedures or supervised challenges, a 'missed dose' usually refers to a missed appointment. If an appointment is missed, it should be rescheduled as soon as possible. There is no risk of 'withdrawal' or 'sub-therapeutic levels' with diagnostic extracts.

An overdose in the context of an allergenic extract refers to the administration of too much allergen, leading to a systemic reaction (anaphylaxis).

• Signs of Overdose: Rapid onset of hives (urticaria), swelling of the throat (angioedema), wheezing, shortness of breath, rapid heart rate, or a sudden drop in blood pressure.
• Emergency Measures: Immediate administration of intramuscular epinephrine (0.3 mg for adults), followed by IV fluids, antihistamines, and corticosteroids. The patient must be transported to an emergency department immediately.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to perform skin tests or oral challenges at home.

Most patients undergoing testing with Eggplant extract will experience localized reactions. These are generally expected and indicate the test is working or that a mild sensitivity exists.

• Localized Pruritus (Itching): A sharp, tingling, or intense itching sensation at the site of the prick. This usually begins within 5 minutes and subsides within an hour.
• Wheal Formation: A raised, pale red bump (similar to a mosquito bite) at the test site. A wheal larger than 3mm is typically considered a positive diagnostic result.
• Flare Reaction: A flat area of redness (erythema) surrounding the wheal. This is caused by localized vasodilation and can persist for several hours.

• Delayed Cutaneous Swelling: Some patients may experience a 'late-phase reaction' where the test site becomes swollen and warm 4 to 8 hours after the procedure.
• Contact Dermatitis: A localized rash that may develop if the glycerin in the extract irritates sensitive skin.
• Gastrointestinal Upset: If an oral challenge is performed, mild nausea or abdominal cramping may occur as the digestive system processes the proteins.

• Vasovagal Response: Fainting or lightheadedness triggered by the needle prick or the sight of the procedure, rather than the extract itself.
• Lymphangitis: Very rarely, a red streak may extend from the test site, indicating localized lymphatic irritation.

> Warning: Stop the procedure and call for emergency assistance if any of the following occur. These are signs of systemic anaphylaxis, a life-threatening emergency.

• Respiratory Distress: Difficulty breathing, tightness in the chest, or a high-pitched gasping sound (stridor).
• Generalized Urticaria: Hives spreading rapidly to parts of the body far from the injection site.
• Angioedema: Significant swelling of the lips, tongue, or throat that may obstruct the airway.
• Hypotension: A sudden feeling of weakness, 'doom,' or loss of consciousness due to a rapid drop in blood pressure.
• Cardiac Arrhythmia: A feeling of the heart racing or skipping beats.

Eggplant extracts used for diagnostic purposes do not typically have long-term side effects. However, repeated exposure to high doses of eggplant phytoestrogens (in supplement form) could theoretically lead to:

• Hormonal Imbalance: Potential changes in menstrual cycle regularity due to estrogen receptor modulation.
• Breast Tenderness: Similar to effects seen with other phytoestrogens like soy isoflavones.

No FDA black box warnings currently exist for Eggplant allergenic extracts. However, the general class of allergenic extracts carries an inherent warning regarding the risk of severe systemic reactions, including anaphylaxis. Facilities administering these extracts must be equipped with 'crash carts' containing epinephrine, oxygen, and airway management tools.

Report any unusual symptoms or persistent skin changes to your healthcare provider immediately.

Eggplant extract must only be administered by healthcare professionals trained in the management of allergic diseases. The most significant risk associated with this substance is the potential for a systemic allergic reaction. Patients should be informed that a negative skin test does not 100% rule out a food allergy, nor does a positive test 100% guarantee a clinical reaction upon ingestion; results must be interpreted in the context of the patient's clinical history.

While there is no specific black box warning for Eggplant, the FDA requires all allergenic extracts to include prominent warnings about Anaphylaxis. The warning states that these products are not for self-administration and should only be used where emergency resuscitative equipment is available.

• Anaphylaxis Risk: Patients with a history of severe reactions to other Solanaceae (tomatoes, peppers, potatoes) are at a higher risk of cross-reactivity and severe reactions to eggplant extract.
• Asthma Status: Patients with unstable or poorly controlled asthma are at a significantly higher risk for a fatal outcome if a systemic reaction occurs during testing. Testing should be postponed until asthma is well-controlled.
• Beta-Blocker Interference: Patients taking beta-blockers may be resistant to the effects of epinephrine, making the treatment of an accidental systemic reaction much more difficult.
• Dermatographism: Patients with 'skin writing' (where any scratch causes a hive) may produce false-positive results, making the extract's diagnostic value unreliable.

• Observation Period: A minimum 30-minute post-administration observation is mandatory.
• Vital Signs: In patients with cardiovascular disease, baseline blood pressure and heart rate should be recorded before testing.
• Lung Function: For patients with a history of asthma, a peak flow or spirometry test may be indicated before proceeding with an oral challenge.

Eggplant extract does not typically cause sedation. However, if a systemic reaction occurs and antihistamines (like diphenhydramine) are administered, the patient should not drive or operate machinery for at least 24 hours due to the resulting drowsiness.

Alcohol consumption should be avoided for 24 hours before and after testing. Alcohol can increase peripheral vasodilation, which may exacerbate the skin's inflammatory response and potentially lower the threshold for a systemic allergic reaction.

There is no tapering requirement for Eggplant extract as it is not used for chronic maintenance. However, if a patient develops a severe reaction, future use of the extract is strictly contraindicated.

> Important: Discuss all your medical conditions, especially respiratory or cardiac issues, with your healthcare provider before starting any testing with Eggplant.

• Beta-Adrenergic Blockers (e.g., Propranolol, Atenolol): These medications are contraindicated during allergenic testing because they block the effects of epinephrine. If a patient has an anaphylactic reaction to the eggplant extract, epinephrine may fail to reverse the airway obstruction or hypotension, leading to a potentially fatal outcome.
• MAO Inhibitors (e.g., Phenelzine): These can potentiate the effects of sympathomimetics used to treat reactions, leading to hypertensive crises.

• Tricyclic Antidepressants (e.g., Amitriptyline): These drugs possess potent H1-receptor blocking activity. They can suppress the skin's response to the eggplant extract for up to 2 weeks, leading to false-negative results.
• Systemic Corticosteroids: Long-term use of prednisone or other steroids can thin the skin and suppress the immune response, potentially masking a positive allergy test.

• H1-Antihistamines (e.g., Cetirizine, Loratadine): These must be discontinued at least 5-7 days before testing. They directly compete with the histamine released during the test, preventing the formation of the diagnostic wheal.
• H2-Antihistamines (e.g., Famotidine): While less potent than H1 blockers, they can still contribute to a reduced skin flare response.

• Other Solanaceae: Consuming tomatoes, potatoes, or tobacco products immediately before testing may cause 'priming' of the mast cells, leading to an exaggerated reaction to the eggplant extract.
• High-Fat Meals: May delay the absorption of oral eggplant supplements, though this does not affect diagnostic skin testing.

• St. John's Wort: May interact with the phytoestrogenic components of eggplant by inducing enzymes that process these compounds, potentially reducing their effectiveness if used for hormonal support.
• Quercetin Supplements: Since eggplant already contains quercetin, supplemental intake may lead to an additive effect on estrogen receptor modulation.

• Skin Prick Tests: Eggplant extract will obviously interfere with other skin tests if applied to the same site.
• Serum IgE: The use of eggplant extract does not typically interfere with blood-based RAST or ImmunoCAP testing.

For each major interaction, the mechanism is usually Pharmacodynamic (interfering with the body's response to the drug) rather than Pharmacokinetic (how the body processes the drug). The management strategy is almost always the temporary discontinuation of the interfering substance under medical supervision.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially any 'over-the-counter' allergy pills.

Eggplant extract must NEVER be used in the following circumstances:

• History of Anaphylaxis to Eggplant: If a patient has previously experienced a life-threatening reaction to eggplant, even a small amount in a skin test could trigger a repeat event.
• Severe, Uncontrolled Asthma: Defined as a FEV1 < 70% of predicted despite therapy. The risk of fatal bronchospasm during a reaction outweighs the diagnostic benefit.
• Acute Infection: Testing during an active fever or viral illness can lead to unpredictable immune responses and false results.
• Generalized Dermatitis: If the skin is covered in eczema or rash, there is no 'clear' site to perform the test and interpret the results accurately.

• Pregnancy: While not strictly prohibited, elective allergy testing is usually postponed until postpartum to avoid the risk of anaphylaxis-induced fetal hypoxia.
• Beta-Blocker Therapy: If the medication cannot be safely paused, the clinician must weigh the diagnostic necessity against the risk of epinephrine resistance.
• Cardiovascular Disease: The stress of a potential reaction or the administration of epinephrine could trigger an underlying cardiac event.

Patients should be screened for cross-sensitivity to:

• Tobacco: Both belong to the Solanaceae family and share common alkaloids.
• Latex: There is a recognized 'Latex-Fruit Syndrome' where patients allergic to latex may cross-react with eggplant proteins.
• Bell Peppers and Tomatoes: Shared profilins and lipid transfer proteins (LTPs) often cause multi-food sensitivities in this group.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing or administering Eggplant extract.

Eggplant extract is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. While the extract itself is not known to be teratogenic (causing birth defects), the primary risk is maternal anaphylaxis. A severe allergic reaction can lead to maternal hypotension and uterine hypoperfusion, resulting in fetal distress or death. Therefore, diagnostic testing with Eggplant is generally deferred until after delivery unless the information is critical for managing a life-threatening nutritional deficiency.

It is not known whether the components of eggplant extract are excreted in human milk. Because systemic absorption from skin testing is minimal, the risk to a nursing infant is considered very low. However, if using concentrated oral supplements, caution is advised as phytoestrogens can theoretically influence milk production or be passed to the infant.

Eggplant extracts are approved for use in children as young as 2 years old for diagnostic purposes. However, the 'prick-to-prick' method (using fresh eggplant) is often preferred by pediatric allergists for its higher sensitivity. Children are more prone to systemic reactions and must be monitored even more closely than adults. It is not approved for use in infants under 6 months of age due to the immaturity of the immune system.

In patients over 65, the skin becomes thinner and less vascularized. This can lead to smaller wheal sizes, potentially resulting in false negatives. Furthermore, elderly patients are more likely to be on interfering medications like beta-blockers or have underlying cardiac conditions that make the use of emergency epinephrine more hazardous. Clinicians should consider serum IgE testing as a safer alternative in this population.

For diagnostic testing, no dose adjustment is needed. For investigational oral use, the phenolic metabolites of eggplant are primarily cleared by the kidneys. In patients with Stage 4 or 5 Chronic Kidney Disease (CKD), these metabolites may accumulate, though the clinical significance of this accumulation is currently unstudied.

In patients with Child-Pugh Class C hepatic impairment, the synthesis of proteins involved in the inflammatory cascade may be reduced. This can blunt the skin's reaction to allergens. Clinicians should be aware that a negative skin test in a patient with end-stage liver disease may not be definitive.

> Important: Special populations require individualized medical assessment and a cautious approach to any allergenic challenge.

Eggplant (Solanum melongena) functions through multiple pharmacological pathways. As an Allergenic Extract, it acts as a ligand for membrane-bound IgE on mast cells and basophils. The binding of eggplant proteins (specifically the Sola m 1 allergen) causes cross-linking of IgE-FcεRI complexes, triggering an influx of calcium ions and subsequent degranulation.

As an Estrogen Receptor Agonist, the flavonoid components (like kaempferol and quercetin) and the anthocyanin nasunin interact with the alpha (α) and beta (β) estrogen receptors. These compounds exhibit a 'selective' modulation effect, often showing higher affinity for ER-β, which is associated with anti-inflammatory and neuroprotective effects.

As an Endoglycosidase, the extract contains enzymes that catalyze the cleavage of internal glycosidic linkages in heparin sulfate and other glycosaminoglycans, which can modify the extracellular matrix and influence cell signaling.

• Onset of Action: For skin testing, the onset is rapid (5-10 minutes). For estrogenic effects, the onset is delayed, requiring several days of consistent oral intake to achieve steady-state modulation.
• Duration of Effect: The localized skin reaction typically resolves within 2-4 hours. The systemic effects of eggplant phenolics last approximately 6-12 hours.
• Tolerance: There is no known tolerance development for the allergenic properties. In fact, repeated exposure can lead to increased sensitization.

| Parameter | Value |

|---|---|

| Bioavailability | < 5% (Skin Prick); ~33% (Oral) |

| Protein Binding | 92% (Phytoestrogens) |

| Half-life | 2.5 - 5 hours |

| Tmax | 1.5 hours (Oral) |

| Metabolism | Hepatic Glucuronidation |

| Excretion | Renal 85%, Fecal 15% |

• Molecular Components: Contains Sola m 1 (14 kDa protein), Nasunin (C36H37O19), and Chlorogenic Acid (C16H18O9).
• Solubility: The extract is highly soluble in water and stabilized in 50% glycerin for clinical use.
• Structure: The primary allergens are acidic proteins, while the estrogenic components are polyphenolic flavonoids.

Eggplant belongs to the Non-Standardized Food Allergenic Extract class. It is grouped with other Solanaceae extracts. Due to its unique chemistry, it is also categorized as a phytoestrogen and a botanical endoglycosidase.